{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:10:40Z","timestamp":1761163840901,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":2464,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1111\/j.1469-0691.2008.01920.x","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T12:04:11Z","timestamp":1284379451000},"page":"1-2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["Serious staphylococcal infections\u2014cyclic lipopeptides: meeting new challenges"],"prefix":"10.1016","volume":"14","author":[{"given":"W.","family":"Graninger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1111\/j.1469-0691.2008.01920.x_bib1","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.1046\/j.1469-0691.2001.00064.x","article-title":"Infections caused by Gram-positive bacteria: situation and challenges of treatment","volume":"7","author":"Bouza","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2008.01920.x_bib2","first-page":"428","article-title":"Prevalence and treatment of Gram-positive infections in internal medicine departments of Spanish hospitals: IGP Study","volume":"16","author":"Gonzalez-Romo","year":"2003","journal-title":"Rev Esp Quimioter"},{"year":"2005","series-title":"European Antimicrobial Resistance Surveillance System Annual Report 2005","key":"10.1111\/j.1469-0691.2008.01920.x_bib3"},{"key":"10.1111\/j.1469-0691.2008.01920.x_bib4","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1001\/archinte.165.15.1756","article-title":"The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database","volume":"165","author":"Noskin","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2008.01920.x_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhin.2005.07.009","article-title":"Economic burden associated with multi-resistant Gram-negative organisms compared with that for methicillin-resistant Staphylococcus aureus in a university teaching hospital","volume":"62","author":"Daxboeck","year":"2006","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1469-0691.2008.01920.x_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/labinvest.3700501","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton\u2013Valentine leukocidin","volume":"87","author":"Boyle-Vavra","year":"2007","journal-title":"Lab Invest"},{"key":"10.1111\/j.1469-0691.2008.01920.x_bib7","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2008.01920.x_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2008.01920.x_bib9","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14609228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14609228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:42:31Z","timestamp":1761068551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14609228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":9,"alternative-id":["S1198743X14609228"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2008.01920.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serious staphylococcal infections\u2014cyclic lipopeptides: meeting new challenges","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1469-0691.2008.01920.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}